Dianthus Therapeutics (DNTH) Receivables - Net (2022 - 2025)

Dianthus Therapeutics' Receivables - Net history runs 4 years deep, the most recent figure standing at $52000.0 for Q4 2025.

• In Q4 2025, Receivables - Net changed N/A year-over-year to $52000.0; the TTM figure through Dec 2025 stood at $52000.0 (changed N/A YoY), while the FY2025 annual figure was $52000.0, down 93.5% from the prior year.
• Receivables - Net for Q4 2025 stood at $52000.0, down from $5.0 million in the prior quarter.
• The five-year high for Receivables - Net was $5.0 million in Q3 2025, with the low at $39000.0 in Q2 2025.
• The 4-year median for Receivables - Net is $637500.0 (2024), against an average of $1.4 million.
• The sharpest annual moves came in 2024 and 2025: Receivables - Net jumped 503.45% in 2024, then plunged 95.36% in 2025.
• Dianthus Therapeutics' Receivables - Net stood at $4.7 million in 2022, then slumped by 93.62% to $300000.0 in 2023, then jumped by 366.67% to $1.4 million in 2024, then plunged by 96.29% to $52000.0 in 2025.
• Business Quant data shows DNTH's Receivables - Net at $52000.0 in Q4 2025, $5.0 million in Q3 2025, and $39000.0 in Q2 2025.